TDOC vs UNH: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
UNH is the larger of the two ($357.88B market cap): the incumbent the market prices for continued execution (17.12x forward earnings, beta 0.52). TDOC is the smaller challenger ($1.58B), priced similarly on forward earnings (-15.60x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
TDOC vs UNH: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | TDOC | UNH | What it tells you |
|---|---|---|---|
| Market cap | $1.58B | $357.88B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | -15.60 | 17.12 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 1.97 | 0.52 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 77% of range | 70% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.22 | 3.65 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how TDOC and UNH affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. TDOC and UNH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined TDOC and UNH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Teladoc Health (TDOC) do?
Teladoc Health makes money through two reporting segments. Integrated Care sells virtual-care services (general medical, chronic-condition management for diabetes and hypertension via the former Livongo programs, expert medical opinions, and licensable platform tools) mostly to employers, health plans, and hospitals on a per-member-per-month and visit-fee basis; in 2025 it was the larger and more profitable engine, with Q2 2026 revenue of about $394 million and a 16.5% adjusted EBITDA margin. BetterHelp is a direct-to-consumer online mental-health and therapy subscription brand whose paying-member count and revenue have been falling; BetterHelp revenue declined about ~9% to roughly ~$950 million in 2025 and its segment adjusted EBITDA fell about ~46% to roughly ~$42 million as marketing costs rose, prompting a pivot toward insurance-reimbursed therapy.
What does UnitedHealth Group (UNH) do?
UnitedHealth Group is the largest US health insurer and one of the largest healthcare companies in the world. It runs through two main engines. UnitedHealthcare is the insurance arm, providing employer, individual, Medicare Advantage, and Medicaid health plans to tens of millions of members. Optum is the faster-growing health-services arm: Optum Health (physician groups and care delivery, including value-based care), Optum Insight (healthcare data, analytics, and technology), and Optum Rx (one of the largest pharmacy benefit managers in the country). The combination lets UnitedHealth manage both the financing and the delivery of care, capturing margin across the system and using vast claims data to manage costs. Headquartered in Minnetonka, Minnesota, UnitedHealth is a Dow component and one of the largest companies in the S&P 500 by revenue. Its scale, vertical integration, and Medicare Advantage leadership define its competitive position.
TDOC vs UNH: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- TDOC drivers: Integrated Care and chronic-condition management; Free cash flow and balance-sheet discipline.
- UNH drivers: Optum growth engine; Medicare Advantage scale.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Revenue has been roughly flat to declining for several years, and total revenue fell about 2% in 2025 and about 4% in Q2 2026, so the turnaround is about stabilization rather than growth. For UNH, unitedHealth faces a difficult medical-cost environment: rising utilization (especially in Medicare Advantage) can spike the medical loss ratio and compress margins, as the company has experienced.
TDOC or UNH: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick TDOC if you believe its drivers more; UNH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the TDOC and UNH guides.
TDOC vs UNH: the full fundamentals
TDOC. As of October 16, 2026, Teladoc trades at about 0.4 times trailing sales and below book value, a valuation that prices in continued revenue decline rather than a turnaround. With GAAP losses ongoing, adjusted EBITDA and free cash flow remain the practical yardsticks, and the $130 to $170 million free cash flow guide equals a large share of the roughly $1.1 billion market cap. Analysts rate it hold on average, with a mean target near $7.59 across 17 firms.
UNH. The trailing P/E of about 26x is inflated by the near-zero fourth quarter of 2025; on forward earnings UNH trades near 17x, closer to its historical range. Revenue is enormous but insurance margins are thin, so the valuation hinges on whether the medical cost trend keeps stabilizing and the raised 2026 outlook holds. The stock has recovered a large part of its 2025 decline, which leaves less of a discount for regulatory and cost risk than a year ago.
Headline figures (approximate, October 2026): TDOC shows revenue (ttm) ~$2.49 billion; Q2 2026 revenue $606.9 million, down ~4% YoY, segment mix (q2 2026) Integrated Care $394.3 million (+1%); BetterHelp $212.6 million (-12%), adjusted ebitda Q2 2026 $65.7 million; FY2026 guidance $271 to $303 million, net income (ttm) ~-$177 million (GAAP loss); Q2 2026 EPS -$0.21 vs ~-$0.22 expected; UNH shows revenue (ttm) ~$450 billion; Q3 2026 ~$112.7 billion, ~flat year on year, operating margin ~5.8% (net margin ~3.5%), net income (ttm) ~$15.9 billion (sensitive to medical costs), eps ~$15.55 trailing; Q3 2026 $4.69 vs $4.14 consensus.
The bottom line: TDOC vs UNH
TDOC and UNH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined TDOC and UNH exposure against your real portfolio. It is not an investment adviser.
Wondering how TDOC or UNH fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Teladoc Health
Ask Walnut's AI anything about TDOC and see how it fits what you own.
FAQ
What is the difference between TDOC and UNH?
+
Teladoc Health makes money through two reporting segments. UnitedHealth Group is the largest US health insurer and one of the largest healthcare companies in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is TDOC or UNH the better stock?
+
Neither is universally better. UNH is the larger incumbent; TDOC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, TDOC or UNH?
+
On forward P/E (as of November 2026), TDOC trades at -15.60x and UNH at 17.12x, so TDOC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both TDOC and UNH?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of TDOC vs UNH?
+
TDOC: Revenue has been roughly flat to declining for several years, and total revenue fell about 2% in 2025 and about 4% in Q2 2026, so the turnaround is about stabilization rather than growth. BetterHelp faces intense competition for therapy customers and rising acquisition costs that have compressed its profitability, and the insurance pivot is unproven at scale. Teladoc still reports GAAP net losses (a net loss of $38.9 million in Q2 2026 and about $177 million over the trailing twelve months) and carries debt, so the equity depends on cash flow and margin execution. Telehealth is crowded, with enterprise rivals, consumer-subscription players, and health plans building their own virtual care. The July 2026 cut to the BetterHelp outlook shows the cash-pay decline can run faster than planned, and the shares lost about 40% in the three months that followed. UNH: UnitedHealth faces a difficult medical-cost environment: rising utilization (especially in Medicare Advantage) can spike the medical loss ratio and compress margins, as the company has experienced. Regulatory and political risk is significant, including Medicare Advantage rate changes, scrutiny of PBM practices, and proposals to limit insurer-provider integration. The company has faced antitrust attention, a major cyberattack on its Change Healthcare unit, and intense public criticism of the insurance industry. Reimbursement is set by government programs that can change with each cycle. Litigation, regulatory fines, and reputational risk are persistent. Its size makes it a target for legislation, and any sustained period of elevated medical costs directly pressures earnings. The 2026 recovery also raises the bar: at roughly 17x forward earnings the stock now prices in continued margin repair, and the September quarter's net income of about $4.1 billion was lower than the $6.3 billion and $5.5 billion of the first two quarters, so the seasonal pattern of medical costs remains a swing factor.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell TDOC or UNH; figures are approximate and dated (as of November 2026). Verify current data before investing.